Tony Berberabe, MPH


International Pediatric Cancer Registry Can Improve Outcomes

May 31, 2020

Pediatric precision oncology in a real-world, multinational setting is feasible. For the subgroup of children with very high priority level targets, the INFORM registry provided therapeutic opportunities and new diagnostic information.

PSA Screening Declines, Especially Among Men Most Likely to Benefit

May 18, 2015

When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians.

Prostate Cancer Screening: "Yes, No, or Maybe?"

March 18, 2015

The continuing contentious debate about screening for prostate cancer remains top of mind among the public and lay press, but, Leonard G. Gomella, MD, told attendees at the 8th International Prostate Cancer Congress, the decision to screen or not to screen boiled down to "using common sense, shared decision making, and choosing the right patients to screen."

Adjuvant Breast Cancer Therapy Poses Challenges for Clinicians

November 07, 2014

In May 2014, ASCO issued guidelines recommending the administration of adjuvant tamoxifen for 10 years in women with stage I-III hormone receptor (HR)-positive breast cancer, based on data from the collection of 5 clinical trials.